The DOI matches its Crossref record; 112 of the 112 references it cites were found in a registry or an index.
Multi-omics approaches in cancer research with applications in tumor subtyping, prognosis, and diagnosis
Open accessAbstract
While cost-effective high-throughput technologies provide an increasing amount of data, the analyses of single layers of data seldom provide causal relations. Multi-omics data integration strategies across different cellular function levels, including genomes, epigenomes, transcriptomes, proteomes, metabolomes, and microbiomes offer unparalleled opportunities to understand the underlying biology of complex diseases, such as cancer. We review some of the most frequently used data integration methods and outline research areas where multi-omics significantly benefit our understanding of the process and outcome of the malignant transformation. We discuss algorithmic frameworks developed to reveal cancer subtypes, disease mechanisms, and methods for identifying driver genomic alterations and consider the significance of multi-omics in tumor classifications, diagnostics, and prognostications. We provide a comprehensive summary of each omics strategy's most recent advances within the clinical context and discuss the main challenges facing their clinical implementations. Despite its unparalleled advantages, multi-omics data integration is slow to enter everyday clinics. One major obstacle is the uneven maturity of different omics approaches and the growing gap between generating large volumes of data compared to data processing capacity. Progressive initiatives to enforce the standardization of sample processing and analytical pipelines, multidisciplinary training of experts for data analysis and interpretation are vital to facilitate the translatability of theoretical findings.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
PD-1 and PD-L1 Immune Checkpoint Blockade to Treat Breast Cancer
Hartkopf, A. D., Taran, F.-A., Wallwiener, M., Walter, C. B., Krämer, B., Grischke, E.-M., & Brucker, S. Y. (2016) · Breast Care · doi:10.1159/000453569 · Cited by 30,845
Molecular portraits of human breast tumours
Perou, C. M., Sørlie, T., Eisen, M. B., van de Rijn, M., Jeffrey, S. S., Rees, C. A., Pollack, J. R., Ross, D. T., Johnsen, H., Akslen, L. A., et al. (2000) · Nature · doi:10.1038/35021093 · Cited by 16,261
Nishimura, R., Osako, T., Nishiyama, Y., Tashima, R., Nakano, M., Fujisue, M., Toyozumi, Y., & Arima, N. (2013) · Oncology · doi:10.1159/000353099 · Cited by 13,166
Comprehensive molecular portraits of human breast tumours
The Cancer Genome Atlas Network (2012) · Nature · doi:10.1038/nature11412 · Cited by 12,129
The cancer genome atlas pan-cancer analysis project
The Cancer Genome Atlas Research Network, Weinstein, J. N., Collisson, E. A., Mills, G. B., Shaw, K. R. M., Ozenberger, B. A., Ellrott, K., Shmulevich, I., Sander, C., & Stuart, J. M. (2013) · Nature Genetics · doi:10.1038/ng.2764 · Cited by 9,092
Integrated genomic analyses of ovarian carcinoma
Perou, C. M. (2019) · Carolina Digital Repository (University of North Carolina at Chapel Hill) · doi:10.17615/hvp3-wg08 · Cited by 7,925
Vogelstein, B., Papadopoulos, N., Velculescu, V. E., Zhou, S., Diaz, L. A., & Kinzler, K. W. (2013) · Science · doi:10.1126/science.1235122 · Cited by 7,863
Mutational landscape determines sensitivity to PD-1 blockade in non–small cell lung cancer
Rizvi, N. A., Hellmann, M. D., Snyder, A., Kvistborg, P., Makarov, V., Havel, J. J., Lee, W., Yuan, J., Wong, P., Ho, T. S., et al. (2015) · Science · doi:10.1126/science.aaa1348 · Cited by 7,802 · cited 1×
“Besides individual targetable alterations, genomics can assess mutational signatures and mutational load to predict immune-checkpoint inhibitors’ effectiveness [49].”
BackgroundGlobal quantification of mammalian gene expression control
Schwanhäusser, B., Busse, D., Li, N., Dittmar, G., Schuchhardt, J., Wolf, J., Chen, W., & Selbach, M. (2011) · Nature · doi:10.1038/nature10098 · Cited by 6,566
The genomic and transcriptomic architecture of 2,000 breast tumours reveals novel subgroups
METABRIC Group, Curtis, C., Shah, S. P., Chin, S.-F., Turashvili, G., Rueda, O. M., Dunning, M. J., Speed, D., Lynch, A. G., Samarajiwa, S., et al. (2012) · Nature · doi:10.1038/nature10983 · Cited by 6,097
Gut microbiome influences efficacy of PD-1-based immunotherapy against epithelial tumors
Routy, B., Le Chatelier, E., Derosa, L., Duong, C. P. M., Alou, M. T., Daillère, R., Fluckiger, A., Messaoudene, M., Rauber, C., Roberti, M. P., et al. (2018) · Science · doi:10.1126/science.aan3706 · Cited by 5,671
The consensus molecular subtypes of colorectal cancer
Guinney, J., Dienstmann, R., Wang, X., de Reyniès, A., Schlicker, A., Soneson, C., Marisa, L., Roepman, P., Nyamundanda, G., Angelino, P., et al. (2015) · Nature Medicine · doi:10.1038/nm.3967 · Cited by 5,170
Detection of Circulating Tumor DNA in Early- and Late-Stage Human Malignancies
Bettegowda, C., Sausen, M., Leary, R. J., Kinde, I., Wang, Y., Agrawal, N., Bartlett, B. R., Wang, H., Luber, B., Alani, R. M., et al. (2014) · Science Translational Medicine · doi:10.1126/scitranslmed.3007094 · Cited by 5,067
Gut microbiome modulates response to anti-PD-1 immunotherapy in melanoma patients
Gopalakrishnan, V., Spencer, C. N., Nezi, L., Reuben, A., Andrews, M. C., Karpinets, T. V., Prieto, P. A., Vicente, D., Hoffman, K., Wei, S. C., et al. (2018) · Science · doi:10.1126/science.aan4236 · Cited by 4,812
Supervised Risk Predictor of Breast Cancer Based on Intrinsic Subtypes
Parker, J. S., Mullins, M., Cheang, M. C. U., Leung, S., Voduc, D., Vickery, T., Davies, S., Fauron, C., He, X., Hu, Z., et al. (2009) · Journal of Clinical Oncology · doi:10.1200/jco.2008.18.1370 · Cited by 4,721
Elkablawy, M. A., Albasri, A. M., Mohammed, R. A., Hussainy, A. S., Nouh, M. M., & Alhujaily, A. S. (2016) · Saudi Medical Journal · doi:10.15537/smj.2016.2.12285 · Cited by 4,382
Insights into the regulation of protein abundance from proteomic and transcriptomic analyses
Vogel, C., & Marcotte, E. M. (2012) · Nature Reviews Genetics · doi:10.1038/nrg3185 · Cited by 4,195
On the Dependency of Cellular Protein Levels on mRNA Abundance
Liu, Y., Beyer, A., & Aebersold, R. (2016) · Cell · doi:10.1016/j.cell.2016.03.014 · Cited by 3,221
The commensal microbiome is associated with anti-PD-1 efficacy in metastatic melanoma patients
Matson, V., Fessler, J., Bao, R., Chongsuwat, T., Zha, Y., Alegre, M.-L., Luke, J. J., & Gajewski, T. F. (2018) · Science · doi:10.1126/science.aao3290 · Cited by 3,107
Multi-omics approaches to disease
Hasin, Y., Seldin, M., & Lusis, A. (2017) · Genome Biology · doi:10.1186/s13059-017-1215-1 · Cited by 2,953
Detection and localization of surgically resectable cancers with a multi-analyte blood test
Cohen, J. D., Li, L., Wang, Y., Thoburn, C., Afsari, B., Danilova, L., Douville, C., Javed, A. A., Wong, F., Mattox, A., et al. (2018) · Science · doi:10.1126/science.aar3247 · Cited by 2,783
The causes and consequences of genetic heterogeneity in cancer evolution
Burrell, R. A., McGranahan, N., Bartek, J., & Swanton, C. (2013) · Nature · doi:10.1038/nature12625 · Cited by 2,262
Similarity network fusion for aggregating data types on a genomic scale
Wang, B., Mezlini, A. M., Demir, F., Fiume, M., Tu, Z., Brudno, M., Haibe-Kains, B., & Goldenberg, A. (2014) · Nature Methods · doi:10.1038/nmeth.2810 · Cited by 2,036
Mass-spectrometry-based draft of the human proteome
Wilhelm, M., Schlegl, J., Hahne, H., Gholami, A. M., Lieberenz, M., Savitski, M. M., Ziegler, E., Butzmann, L., Gessulat, S., Marx, H., et al. (2014) · Nature · doi:10.1038/nature13319 · Cited by 1,820
Proteogenomics connects somatic mutations to signalling in breast cancer
CPTAC, N., Mertins, P., Mani, D. R., Ruggles, K. V., Gillette, M. A., Clauser, K. R., Wang, P., Wang, X., Qiao, J. W., Cao, S., et al. (2016) · Nature · doi:10.1038/nature18003 · Cited by 1,676
Multi-omics Data Integration, Interpretation, and Its Application
Subramanian, I., Verma, S., Kumar, S., Jere, A., & Anamika, K. (2020) · Bioinformatics and Biology Insights · doi:10.1177/1177932219899051 · Cited by 1,609
Multi-Omics Factor Analysis—a framework for unsupervised integration of multi-omics data sets
Argelaguet, R., Velten, B., Arnol, D., Dietrich, S., Zenz, T., Marioni, J. C., Buettner, F., Huber, W., & Stegle, O. (2018) · Molecular Systems Biology · doi:10.15252/msb.20178124 · Cited by 1,510
Prospective Validation of a 21-Gene Expression Assay in Breast Cancer
Sparano, J. A., Gray, R. J., Makower, D. F., Pritchard, K. I., Albain, K. S., Hayes, D. F., Geyer, C. E., Dees, E. C., Perez, E. A., Olson, J. A., et al. (2015) · New England Journal of Medicine · doi:10.1056/nejmoa1510764 · Cited by 1,388
Comprehensive and Integrated Genomic Characterization of Adult Soft Tissue Sarcomas
Abeshouse, A., Adebamowo, C., Adebamowo, S. N., Akbani, R., Akeredolu, T., Ally, A., Anderson, M. L., Anur, P., Appelbaum, E. L., Armenia, J., et al. (2017) · Cell · doi:10.1016/j.cell.2017.10.014 · Cited by 1,069
Integrated Proteogenomic Characterization of Human High-Grade Serous Ovarian Cancer
Zhang, H., Liu, T., Zhang, Z., Payne, S. H., Zhang, B., McDermott, J. E., Zhou, J.-Y., Petyuk, V. A., Chen, L., Ray, D., et al. (2016) · Cell · doi:10.1016/j.cell.2016.05.069 · Cited by 1,029
Proteomics identifies new therapeutic targets of early-stage hepatocellular carcinoma
Chinese Human Proteome Project (CNHPP) Consortium, Jiang, Y., Sun, A., Zhao, Y., Ying, W., Sun, H., Yang, X., Xing, B., Sun, W., Ren, L., et al. (2019) · Nature · doi:10.1038/s41586-019-0987-8 · Cited by 947
Infiltrating lobular carcinoma of the breast: tumor characteristics and clinical outcome
Arpino, G., Bardou, V. J., Clark, G. M., & Elledge, R. M. (2004) · Breast Cancer Research · doi:10.1186/bcr767 · Cited by 865
Shen, R., Olshen, A. B., & Ladanyi, M. (2009) · Bioinformatics · doi:10.1093/bioinformatics/btp543 · Cited by 849
Proteogenomic Analysis of Human Colon Cancer Reveals New Therapeutic Opportunities
Vasaikar, S., Huang, C., Wang, X., Petyuk, V. A., Savage, S. R., Wen, B., Dou, Y., Zhang, Y., Shi, Z., Arshad, O. A., et al. (2019) · Cell · doi:10.1016/j.cell.2019.03.030 · Cited by 799
Vaske, C. J., Benz, S. C., Sanborn, J. Z., Earl, D., Szeto, C., Zhu, J., Haussler, D., & Stuart, J. M. (2010) · Bioinformatics · doi:10.1093/bioinformatics/btq182 · Cited by 786
The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma
Ricketts, C. J., De Cubas, A. A., Fan, H., Smith, C. C., Lang, M., Reznik, E., Bowlby, R., Gibb, E. A., Akbani, R., Beroukhim, R., et al. (2018) · Cell Reports · doi:10.1016/j.celrep.2018.06.032 · Cited by 734
Role of oncogenic KRAS in the diagnosis, prognosis and treatment of pancreatic cancer
Buscail, L., Bournet, B., & Cordelier, P. (2020) · Nature Reviews Gastroenterology & Hepatology · doi:10.1038/s41575-019-0245-4 · Cited by 721
More Is Better: Recent Progress in Multi-Omics Data Integration Methods
Huang, S., Chaudhary, K., & Garmire, L. X. (2017) · Frontiers in Genetics · doi:10.3389/fgene.2017.00084 · Cited by 702
Integrated omics: tools, advances and future approaches
Misra, B. B., Langefeld, C., Olivier, M., & Cox, L. A. (2019) · Journal of Molecular Endocrinology · doi:10.1530/jme-18-0055 · Cited by 686 · cited 1×
“Excellent comprehensive descriptions from several perspectives are available elsewhere [6–11], discussing data resources [6], multi-omics fusion methods ideal for matched samples [7], comparing supervised, semi-supervised, and unsupervised integrative approaches [8], examining the development of standardized analytica…”
BackgroundTie, J., Kinde, I., Wang, Y., Wong, H. L., Roebert, J., Christie, M., Tacey, M., Wong, R., Singh, M., Karapetis, C. S., et al. (2015) · Annals of Oncology · doi:10.1093/annonc/mdv177 · Cited by 635
The emerging clinical relevance of genomics in cancer medicine
Berger, M. F., & Mardis, E. R. (2018) · Nature Reviews Clinical Oncology · doi:10.1038/s41571-018-0002-6 · Cited by 626
Cohen, J. D., Javed, A. A., Thoburn, C., Wong, F., Tie, J., Gibbs, P., Schmidt, C. M., Yip-Schneider, M. T., Allen, P. J., Schattner, M., et al. (2017) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1704961114 · Cited by 582
Shen, R., Olshen, A. B., & Ladanyi, M. (2010) · Bioinformatics · doi:10.1093/bioinformatics/btp659 · Cited by 566
From big data analysis to personalized medicine for all: challenges and opportunities
Alyass, A., Turcotte, M., & Meyre, D. (2015) · BMC Medical Genomics · doi:10.1186/s12920-015-0108-y · Cited by 557
Multi-omic and multi-view clustering algorithms: review and cancer benchmark
Rappoport, N., & Shamir, R. (2018) · Nucleic Acids Research · doi:10.1093/nar/gky889 · Cited by 553
Joint and individual variation explained (JIVE) for integrated analysis of multiple data types
Lock, E. F., Hoadley, K. A., Marron, J. S., & Nobel, A. B. (2013) · The Annals of Applied Statistics · doi:10.1214/12-aoas597 · Cited by 552
Wolf-Yadlin, A., Hautaniemi, S., Lauffenburger, D. A., & White, F. M. (2007) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0608638104 · Cited by 493
Gene‐specific correlation of RNA and protein levels in human cells and tissues
Edfors, F., Danielsson, F., Hallström, B. M., Käll, L., Lundberg, E., Pontén, F., Forsström, B., & Uhlén, M. (2016) · Molecular Systems Biology · doi:10.15252/msb.20167144 · Cited by 493
Pattern discovery and cancer gene identification in integrated cancer genomic data
Mo, Q., Wang, S., Seshan, V. E., Olshen, A. B., Schultz, N., Sander, C., Powers, R. S., Ladanyi, M., & Shen, R. (2013) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1208949110 · Cited by 474 · cited 3×
“iCluster+ can identify genomic features that contribute most to the biological variation with a lasso regression [20].”
BackgroundMethodMYC-driven accumulation of 2-hydroxyglutarate is associated with breast cancer prognosis
Terunuma, A., Putluri, N., Mishra, P., Mathé, E. A., Dorsey, T. H., Yi, M., Wallace, T. A., Issaq, H. J., Zhou, M., Killian, J. K., et al. (2014) · Journal of Clinical Investigation · doi:10.1172/jci71180 · Cited by 428
Oncometabolites: linking altered metabolism with cancer
Yang, M., Soga, T., & Pollard, P. J. (2013) · Journal of Clinical Investigation · doi:10.1172/jci67228 · Cited by 422
Doebele, R. C., Davis, L. E., Vaishnavi, A., Le, A. T., Estrada-Bernal, A., Keysar, S., Jimeno, A., Varella-Garcia, M., Aisner, D. L., Li, Y., et al. (2015) · Cancer Discovery · doi:10.1158/2159-8290.cd-15-0443 · Cited by 388
Discovery of multi-dimensional modules by integrative analysis of cancer genomic data
Zhang, S., Liu, C.-C., Li, W., Shen, H., Laird, P. W., & Zhou, X. J. (2012) · Nucleic Acids Research · doi:10.1093/nar/gks725 · Cited by 374
Barriers and Advances in Kidney Preservation
Steichen, C., Giraud, S., Bon, D., Barrou, B., Badet, L., Salamé, E., Kerforne, T., Allain, G., Roumy, J., Jayle, C., et al. (2018) · BioMed Research International · doi:10.1155/2018/9206257 · Cited by 370
Onco-Multi-OMICS Approach: A New Frontier in Cancer Research
Chakraborty, S., Hosen, M. I., Ahmed, M., & Shekhar, H. U. (2018) · BioMed Research International · doi:10.1155/2018/9836256 · Cited by 335
Metabolomics in cancer biomarker discovery: Current trends and future perspectives
Armitage, E. G., & Barbas, C. (2014) · Journal of Pharmaceutical and Biomedical Analysis · doi:10.1016/j.jpba.2013.08.041 · Cited by 331
Yan, J., Risacher, S. L., Shen, L., & Saykin, A. J. (2017) · Briefings in Bioinformatics · doi:10.1093/bib/bbx066 · Cited by 325
Ellis, M. J., Gillette, M., Carr, S. A., Paulovich, A. G., Smith, R. D., Rodland, K. K., Townsend, R. R., Kinsinger, C., Mesri, M., Rodriguez, H., et al. (2013) · Cancer Discovery · doi:10.1158/2159-8290.cd-13-0219 · Cited by 309
Lock, E. F., & Dunson, D. B. (2013) · Bioinformatics · doi:10.1093/bioinformatics/btt425 · Cited by 306
DriverNet: uncovering the impact of somatic driver mutations on transcriptional networks in cancer
Bashashati, A., Haffari, G., Ding, J., Ha, G., Lui, K., Rosner, J., Huntsman, D. G., Caldas, C., Aparicio, S. A., & Shah, S. P. (2012) · Genome Biology · doi:10.1186/gb-2012-13-12-r124 · Cited by 302
Emerging roles for chromatin as a signal integration and storage platform
Badeaux, A. I., & Shi, Y. (2013) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm3545 · Cited by 291 · cited 1×
“Chemical modifications of DNA, nuclear RNA, histones, and nonhistone chromatin proteins may affect gene expression without altering the base sequence [56].”
BackgroundNEMO: cancer subtyping by integration of partial multi-omic data
Rappoport, N., & Shamir, R. (2019) · Bioinformatics · doi:10.1093/bioinformatics/btz058 · Cited by 286 · cited 4×
“Extensive testing on full data spanning over three thousand patients samples in 10 cancer types revealed results comparable to previous data integration methods [32].”
MethodResultInfluentialA fully Bayesian latent variable model for integrative clustering analysis of multi-type omics data
Mo, Q., Shen, R., Guo, C., Vannucci, M., Chan, K. S., & Hilsenbeck, S. G. (2018) · Biostatistics · doi:10.1093/biostatistics/kxx017 · Cited by 280
Li, J. J., Bickel, P. J., & Biggin, M. D. (2014) · PeerJ · doi:10.7717/peerj.270 · Cited by 279
Krug, A. K., Enderle, D., Karlovich, C., Priewasser, T., Bentink, S., Spiel, A., Brinkmann, K., Emenegger, J., Grimm, D. G., Castellanos-Rizaldos, E., et al. (2018) · Annals of Oncology · doi:10.1093/annonc/mdx765 · Cited by 271
Multigene prognostic tests in breast cancer: past, present, future
Győrffy, B., Hatzis, C., Sanft, T., Hofstatter, E., Aktas, B., & Pusztai, L. (2015) · Breast Cancer Research · doi:10.1186/s13058-015-0514-2 · Cited by 257
Self-citationBayesian correlated clustering to integrate multiple datasets
Kirk, P., Griffin, J. E., Savage, R. S., Ghahramani, Z., & Wild, D. L. (2012) · Bioinformatics · doi:10.1093/bioinformatics/bts595 · Cited by 228
Ren, S., Shao, Y., Zhao, X., Hong, C. S., Wang, F., Lu, X., Li, J., Ye, G., Yan, M., Zhuang, Z., et al. (2016) · Molecular & Cellular Proteomics · doi:10.1074/mcp.m115.052381 · Cited by 215
A Selective Review of Multi-Level Omics Data Integration Using Variable Selection
Wu, C., Zhou, F., Ren, J., Li, X., Jiang, Y., & Ma, S. (2019) · High-Throughput · doi:10.3390/ht8010004 · Cited by 213
Tebani, A., Afonso, C., Marret, S., & Bekri, S. (2016) · International Journal of Molecular Sciences · doi:10.3390/ijms17091555 · Cited by 212
Applications of liquid biopsies for cancer
Mattox, A. K., Bettegowda, C., Zhou, S., Papadopoulos, N., Kinzler, K. W., & Vogelstein, B. (2019) · Science Translational Medicine · doi:10.1126/scitranslmed.aay1984 · Cited by 195
Speicher, N. K., & Pfeifer, N. (2015) · Bioinformatics · doi:10.1093/bioinformatics/btv244 · Cited by 185
The challenges of integrating multi-omic data sets
Palsson, B., & Zengler, K. (2010) · Nature Chemical Biology · doi:10.1038/nchembio.462 · Cited by 178
iBAG: integrative Bayesian analysis of high-dimensional multiplatform genomics data
Wang, W., Baladandayuthapani, V., Morris, J. S., Broom, B. M., Manyam, G. C., & Do, K.-A. (2012) · Bioinformatics · doi:10.1093/bioinformatics/bts655 · Cited by 173
Michaut, M., Chin, S.-F., Majewski, I., Severson, T. M., Bismeijer, T., de Koning, L., Peeters, J. K., Schouten, P. C., Rueda, O. M., Bosma, A. J., et al. (2016) · Scientific Reports · doi:10.1038/srep18517 · Cited by 173
Guidelines for the selection of functional assays to evaluate the hallmarks of cancer
Menyhárt, O., Papp, H., Sukumar, S. V., Schäfer, R., Magnani, L., de Barrios, O., & Győrffy, B. (2016) · Biochimica et Biophysica Acta (BBA) - Reviews on Cancer · doi:10.1016/j.bbcan.2016.10.002 · Cited by 167
Self-citationMicroarrays--Guilt by Association
Quackenbush, J. (2003) · Science · doi:10.1126/science.1090887 · Cited by 164
Wang, J., Ma, Z., Carr, S. A., Mertins, P., Zhang, H., Zhang, Z., Chan, D. W., Ellis, M. J. C., Townsend, R. R., Smith, R. D., et al. (2017) · Molecular & Cellular Proteomics · doi:10.1074/mcp.m116.060301 · Cited by 160
Network-based integration of multi-omics data for prioritizing cancer genes
Dimitrakopoulos, C., Hindupur, S. K., Häfliger, L., Behr, J., Montazeri, H., Hall, M. N., & Beerenwinkel, N. (2018) · Bioinformatics · doi:10.1093/bioinformatics/bty148 · Cited by 160
Changes in correlation between promoter methylation and gene expression in cancer
Moarii, M., Boeva, V., Vert, J., & Reyal, F. (2015) · BMC Genomics · doi:10.1186/s12864-015-1994-2 · Cited by 159
Masica, D. L., & Karchin, R. (2011) · Cancer Research · doi:10.1158/0008-5472.can-11-0180 · Cited by 159
moCluster: Identifying Joint Patterns Across Multiple Omics Data Sets
Meng, C., Helm, D., Frejno, M., & Küster, B. (2015) · Journal of Proteome Research · doi:10.1021/acs.jproteome.5b00824 · Cited by 157
Wang, Y., Zhang, C., Zhang, P., Guo, G., Jiang, T., Zhao, X., Jiang, J., Huang, X., Tong, H., & Tian, Y. (2018) · Cancer Medicine · doi:10.1002/cam4.1390 · Cited by 148
The microbiome in precision medicine: the way forward
Petrosino, J. F. (2018) · Genome Medicine · doi:10.1186/s13073-018-0525-6 · Cited by 142
muTarget : A platform linking gene expression changes and mutation status in solid tumors
Nagy, Á. M., & Győrffy, B. (2020) · International Journal of Cancer · doi:10.1002/ijc.33283 · Cited by 141
Self-citationiOmicsPASS: network-based integration of multiomics data for predictive subnetwork discovery
Koh, H. W. L., Fermin, D., Vogel, C., Choi, K. P., Ewing, R. M., & Choi, H. (2019) · npj Systems Biology and Applications · doi:10.1038/s41540-019-0099-y · Cited by 139
Li, L., Wei, Y., To, C., Zhu, C., Tong, J., Pham, N., Taylor, P. P., Ignatchenko, V., Ignatchenko, A., Zhang, W., et al. (2014) · Nature Communications · doi:10.1038/ncomms6469 · Cited by 129
Group sparse canonical correlation analysis for genomic data integration
Lin, D., Zhang, J.-G., Li, J., Calhoun, V., Deng, H.-W., & Wang, Y.-P. (2013) · BMC Bioinformatics · doi:10.1186/1471-2105-14-245 · Cited by 114
Microscaled proteogenomic methods for precision oncology
Satpathy, S., Jaehnig, E. J., Krug, K., Kim, B., Saltzman, A. B., Chan, D. W., Holloway, K. R., Anurag, M., Huang, C. L., Singh, P., et al. (2020) · Nature Communications · doi:10.1038/s41467-020-14381-2 · Cited by 113
Metabolomics Applications in Precision Medicine: An Oncological Perspective
Puchades‐Carrasco, L., & Pineda‐Lucena, A. (2017) · Current Topics in Medicinal Chemistry · doi:10.2174/1568026617666170707120034 · Cited by 105
Statistical Methods in Integrative Genomics
Richardson, S. T., Tseng, G. C., & Sun, W. (2016) · Annual Review of Statistics and Its Application · doi:10.1146/annurev-statistics-041715-033506 · Cited by 101
Wilson, S. P., Fan, L., Sahgal, N., Qi, J., & Filipp, F. V. (2017) · Oncotarget · doi:10.18632/oncotarget.15681 · Cited by 100
Pattern fusion analysis by adaptive alignment of multiple heterogeneous omics data
Shi, Q., Zhang, C., Peng, M., Yu, X., Zeng, T., Liu, J., & Chen, L. (2017) · Bioinformatics · doi:10.1093/bioinformatics/btx176 · Cited by 94
Advancing translational research and precision medicine with targeted proteomics
Uzozie, A. C., & Aebersold, R. H. (2018) · Journal of Proteomics · doi:10.1016/j.jprot.2018.02.021 · Cited by 93
Integrated RNA and DNA sequencing improves mutation detection in low purity tumors
Wilkerson, M. D., Cabanski, C. R., Sun, W., Hoadley, K. A., Walter, V., Mose, L. E., Troester, M. A., Hammerman, P. S., Parker, J. S., Perou, C. M., et al. (2014) · Nucleic Acids Research · doi:10.1093/nar/gku489 · Cited by 87
A Comprehensive Analysis of Metabolomics and Transcriptomics in Cervical Cancer
Yang, K., Xia, B., Wang, W.-J., Cheng, J., Yin, M., Xie, H., Li, J., Ma, L., Yang, C.-Y., Li, A., et al. (2017) · Scientific Reports · doi:10.1038/srep43353 · Cited by 84
Sathyanarayanan, A., Gupta, R., Thompson, E. W., Nyholt, D. R., Bauer, D. C., & Nagaraj, S. H. (2019) · Briefings in Bioinformatics · doi:10.1093/bib/bbz121 · Cited by 82
Kelley, D. Z., Flam, E. L., Izumchenko, E., Danilova, L., Wulf, H. A., Guo, T. W., Singman, D. A., Afsari, B., Skaist, A. M., Considine, M., et al. (2017) · Cancer Research · doi:10.1158/0008-5472.can-17-0833 · Cited by 76
Similar gene expression profiles do not imply similar tissue functions
Yanai, I., Korbel, J. O., Boué, S., McWeeney, S. K., Bork, P., & Lercher, M. J. (2006) · Trends in Genetics · doi:10.1016/j.tig.2006.01.006 · Cited by 68
Integrative Analysis of Omics Big Data
Yu, X., & Zeng, T. (2018) · Methods in molecular biology · doi:10.1007/978-1-4939-7717-8_7 · Cited by 68
MammaPrint guides treatment decisions in breast Cancer: results of the IMPACt trial
Soliman, H., Shah, V., Srkalovic, G., Mahtani, R., Levine, E., Mavromatis, B., Srinivasiah, J., Kassar, M., Gabordi, R., Qamar, R., et al. (2020) · BMC Cancer · doi:10.1186/s12885-020-6534-z · Cited by 65
Tiffen, J. C., Wilson, S. P., Gallagher, S. J., Hersey, P., & Filipp, F. V. (2016) · Neoplasia · doi:10.1016/j.neo.2016.01.003 · Cited by 56
Auslander, N., Yizhak, K., Weinstock, A., Budhu, A., Tang, W., Wang, X. W., Ambs, S., & Ruppin, E. (2016) · Scientific Reports · doi:10.1038/srep29662 · Cited by 50
Epigenetic profiling joins personalized cancer medicine
Heyn, H., Méndez‐González, J., & Esteller, M. (2013) · Expert Review of Molecular Diagnostics · doi:10.1586/erm.13.36 · Cited by 43
Nagy, Á. M., Pongor, L. S., Szabó, A., Santarpía, M., & Győrffy, B. (2016) · International Journal of Cancer · doi:10.1002/ijc.30509 · Cited by 40
Self-citationOn fusion methods for knowledge discovery from multi-omics datasets
Baldwin, E., Han, J., Luo, W., Zhou, J. J., An, L., Liu, J., Zhang, H. H., & Li, H. (2020) · Computational and Structural Biotechnology Journal · doi:10.1016/j.csbj.2020.02.011 · Cited by 34
Mutations Defining Patient Cohorts With Elevated PD-L1 Expression in Gastric Cancer
Menyhárt, O., Pongor, L. S., & Győrffy, B. (2019) · Frontiers in Pharmacology · doi:10.3389/fphar.2018.01522 · Cited by 31
Self-citationToward Multiomics-Based Next-Generation Diagnostics for Precision Medicine
Wang, Q., Peng, W.-X., Wang, L., & Li, Y. (2019) · Personalized Medicine · doi:10.2217/pme-2018-0085 · Cited by 26
Tsai, E. A., Shakbatyan, R., Evans, J. T., Rossetti, P., Graham, C., Sharma, H., Lin, C., & Lebo, M. S. (2016) · Journal of Personalized Medicine · doi:10.3390/jpm6010012 · Cited by 25
CCA based multi-view feature selection for multi-omics data integration
EL‐Manzalawy, Y. (2018) · IEEE Conference on Computational Intelligence in Bioinformatics and Computational Biology (CIBCB) · doi:10.1109/cibcb.2018.8404968 · Cited by 22
Cancer genomics guide clinical practice in personalized medicine
Lehmann‐Che, J., Poirot, B., Boyer, J.-C., & Evrard, A. (2017) · Therapies · doi:10.1016/j.therap.2016.09.015 · Cited by 14
ICan: An Integrated Co-Alteration Network to Identify Ovarian Cancer-Related Genes
Zhou, Y., Liu, Y., Li, K., Zhang, R., Qiu, F., Zhao, N., & Xu, Y. (2015) · PLoS ONE · doi:10.1371/journal.pone.0116095 · Cited by 12
Cited by
Integration strategies of multi-omics data for machine learning analysis
Picard, M., Scott-Boyer, M.-P., Bodein, A., Périn, O., & Droit, A. (2021) · Computational and Structural Biotechnology Journal · doi:10.1016/j.csbj.2021.06.030 · Cited by 696
Early Diagnosis of Lung Cancer: The Urgent Need of a Clinical Test
Gasparri, R., Guaglio, A., & Spaggiari, L. (2022) · Journal of Clinical Medicine · doi:10.3390/jcm11154398 · Cited by 7
Deep Trans-Omic Network Fusion for Molecular Mechanism of Alzheimer’s Disease
Xie, L., Raj, Y., Varathan, P., He, B., Yu, M., Nho, K., Salama, P., Saykin, A. J., & Yan, J. (2024) · Journal of Alzheimer's Disease · doi:10.3233/jad-240098 · Cited by 2
Metadata
- Authors
- Menyhárt, O., & Győrffy, B.
- Venue
- Computational and Structural Biotechnology Journal
- Published
- 2021
- Volume
- 19
- Pages
- 949-960
- ISSN
- 2001-0370 (ISSN-L)
- OpenAlex
- W3124379712
- Cited by
- 380
- References
- 112
- FWCI
- 13.62
- Type
- journal article
- Language
- en
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.